Updates on Overcoming Bicalutamide Resistance: A Glimpse into Resistance to a Novel Antiandrogen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Updates on Overcoming Bicalutamide Resistance: A Glimpse into Resistance to a Novel Antiandrogen

Published:2024-03-07 Issue:4 Volume:7 Page:905-914
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Izady Mehrnaz¹²,Khatami Fatemeh¹,Ahadi Zeinab¹,Roudgari Hassan³⁴,Aghamir Seyed Mohammad Kazem¹^ORCID

Affiliation:

1. Urology Research Center, Tehran University of Medical Sciences, Tehran 1416753955, Iran

2. Department of Stem Cells Technology and Tissue Regeneration, School of Biology, College of Science, University of Tehran, Tehran 1417614411, Iran

3. Genomic Research Center (GRC), Shahid Beheshti University of Medical Sciences (SBMU), Tehran 19839-63113, Iran

4. Department of Applied Medicine, Medical School, Aberdeen University, Aberdeen AB24 3FX, United Kingdom

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00299

Reference65 articles.

1. A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results

2. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

3. Metabolic alterations drive enzalutamide resistance

4. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer

5. Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP